Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer
AbstractAim: This comprehensive review aims to explore the potential applications of Gastrin-releasing peptide receptor (GRPR) in the diagnosis and treatment of prostate cancer. Additionally, the study investigates the role of GRPR in prognostic assessment for individuals afflicted with prostate can...
| Autori principali: | , , , |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Taylor & Francis Group
2024-12-01
|
| Serie: | Annals of Medicine |
| Soggetti: | |
| Accesso online: | https://www.tandfonline.com/doi/10.1080/07853890.2024.2320301 |